• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

常见慢性肝病中的肝内胆汁淤积。

Intrahepatic cholestasis in common chronic liver diseases.

机构信息

Department of Medicine II, Saarland University Medical Center, Homburg, Germany.

出版信息

Eur J Clin Invest. 2013 Oct;43(10):1069-83. doi: 10.1111/eci.12128. Epub 2013 Aug 8.

DOI:10.1111/eci.12128
PMID:23927644
Abstract

BACKGROUND AND OBJECTIVE

Cholestasis represents the consequence of impaired bile formation and decrease in bile flow, generally classified as extra- and intrahepatic. Cholestasis is the pivotal hallmark of the so-called primary cholestatic liver diseases but may also emerge in other forms of chronic liver injury. The aim now was to summarise the current state of knowledge on intrahepatic cholestasis related to chronic liver diseases.

METHODS

For this overview on intrahepatic cholestasis in chronic liver disorders other than the 'classic' cholestatic liver diseases, selected references were retrieved by literature search in MEDLINE and textbooks were reviewed. All articles were selected that discussed pathophysiological and clinical aspects of intrahepatic cholestasis in the context of alcoholic liver disease, nonalcoholic fatty liver disease, chronic hepatitis B and C virus infections as well as drug-induced and granulomatous liver diseases. Titles referring to primary biliary cirrhosis and sclerosing cholangitis were excluded.

RESULTS AND CONCLUSIONS

Dependent on the aetiology, intrahepatic cholestasis is present at variable frequencies and in different disease stages in chronic liver diseases. Cholestasis secondary to chronic liver injury may denote a severe disease course and development of end-stage liver disease or specific disease variants. These findings indicate that 'secondary intrahepatic cholestasis' (SIC) can occur in the natural course of chronic liver diseases other than the primary cholestatic diseases, in particular in the setting of advanced disease progression.

摘要

背景和目的

胆汁淤积代表胆汁形成受损和胆汁流量减少的结果,通常分为肝外和肝内胆汁淤积。胆汁淤积是所谓原发性胆汁淤积性肝病的关键标志,但也可能出现在其他形式的慢性肝损伤中。现在的目的是总结目前关于慢性肝病中与肝内胆汁淤积相关的知识状况。

方法

为了综述慢性肝病中除“经典”胆汁淤积性肝病以外的肝内胆汁淤积,通过 MEDLINE 文献检索和教科书回顾检索了选定的参考文献。所有讨论了酒精性肝病、非酒精性脂肪性肝病、慢性乙型和丙型肝炎病毒感染以及药物诱导和肉芽肿性肝病背景下肝内胆汁淤积的病理生理和临床方面的文章都被选中。排除了标题涉及原发性胆汁性肝硬化和硬化性胆管炎的文章。

结果和结论

根据病因,慢性肝病中肝内胆汁淤积的发生频率和疾病阶段各不相同。慢性肝损伤引起的胆汁淤积可能表示严重的疾病过程和终末期肝病或特定疾病变异的发展。这些发现表明,除原发性胆汁淤积性疾病外,慢性肝病的自然病程中可能会出现“继发性肝内胆汁淤积(SIC)”,特别是在疾病进展到晚期的情况下。

相似文献

1
Intrahepatic cholestasis in common chronic liver diseases.常见慢性肝病中的肝内胆汁淤积。
Eur J Clin Invest. 2013 Oct;43(10):1069-83. doi: 10.1111/eci.12128. Epub 2013 Aug 8.
2
[Intrahepatic cholestasis in chronic liver disease].[慢性肝病中的肝内胆汁淤积]
Ann Ital Med Int. 1996 Oct;11 Suppl 2:48S-52S.
3
Differential diagnosis, laboratory tests and histology in 245 patients with cholestasis.245例胆汁淤积患者的鉴别诊断、实验室检查及组织学研究
Acta Hepatogastroenterol (Stuttg). 1979 Oct;26(5):375.
4
Cholestatic liver diseases: slow progress in understanding and treating slowly progressive disorders.胆汁淤积性肝病:在理解和治疗缓慢进展性疾病方面进展缓慢。
Scand J Gastroenterol Suppl. 2000(232):86-92.
5
[Importance of liver puncture biopsy and endoscopic retrograde cholangiography in patients with chronic anicteric unexplained cholestasis. A retrospective study in 79 patients].[肝穿刺活检和内镜逆行胆管造影在慢性无黄疸型不明原因胆汁淤积患者中的重要性。对79例患者的回顾性研究]
Gastroenterol Clin Biol. 1999 Feb;23(2):178-85.
6
Variant forms of cholestatic diseases involving small bile ducts in adults.成人累及小胆管的胆汁淤积性疾病的变异形式。
Am J Gastroenterol. 2000 May;95(5):1130-8. doi: 10.1111/j.1572-0241.2000.01999.x.
7
[Role of cholestasis in development of copper metabolism disorder in patients with chronic liver disease].[胆汁淤积在慢性肝病患者铜代谢紊乱发生中的作用]
Eksp Klin Gastroenterol. 2009(3):9-12.
8
Genetic variations of bile salt transporters as predisposing factors for drug-induced cholestasis, intrahepatic cholestasis of pregnancy and therapeutic response of viral hepatitis.胆盐转运蛋白的遗传变异作为药物性胆汁淤积、妊娠肝内胆汁淤积和病毒性肝炎治疗反应的易患因素。
Expert Opin Drug Metab Toxicol. 2011 Apr;7(4):411-25. doi: 10.1517/17425255.2011.557067. Epub 2011 Feb 15.
9
[Cholestatic liver diseases].[胆汁淤积性肝病]
Ther Umsch. 1997 Nov;54(11):639-44.
10
[Treatment of cholestatic liver diseases; the role of ursodeoxycholic acid].[胆汁淤积性肝病的治疗;熊去氧胆酸的作用]
Z Gastroenterol. 1992 Oct;30(10):743-7.

引用本文的文献

1
Disrupting bile acid metabolism by suppressing Fxr causes hepatocellular carcinoma induced by YAP activation.通过抑制法尼醇X受体(Fxr)破坏胆汁酸代谢会导致由Yes相关蛋白(YAP)激活诱导的肝细胞癌。
Nat Commun. 2025 Apr 15;16(1):3583. doi: 10.1038/s41467-025-58809-z.
2
Neutrophil extracellular traps induce intrahepatic thrombotic tendency and liver damage in cholestatic liver disease.中性粒细胞胞外诱捕网可诱发胆汁淤积性肝病的肝内血栓形成倾向和肝损伤。
Hepatol Commun. 2024 Aug 5;8(8). doi: 10.1097/HC9.0000000000000513. eCollection 2024 Aug 1.
3
The biochemical pattern defines MASLD phenotypes linked to distinct histology and prognosis.
该生化模式定义了与不同组织学和预后相关的 MASLD 表型。
J Gastroenterol. 2024 Jul;59(7):586-597. doi: 10.1007/s00535-024-02098-8. Epub 2024 Apr 15.
4
Quantitative Evaluation by Digital Pathology of Immunohistochemical Expression of CK7, CK19, and EpCAM in Advanced Stages of NASH.非酒精性脂肪性肝炎晚期CK7、CK19和EpCAM免疫组化表达的数字病理学定量评估
Biomedicines. 2024 Feb 16;12(2):440. doi: 10.3390/biomedicines12020440.
5
The Role of Inflammation in Cholestatic Liver Injury.炎症在胆汁淤积性肝损伤中的作用。
J Inflamm Res. 2023 Oct 13;16:4527-4540. doi: 10.2147/JIR.S430730. eCollection 2023.
6
Cholestasis: exploring the triangular relationship of gut microbiota-bile acid-cholestasis and the potential probiotic strategies.胆汁淤积症:探索肠道微生物群-胆汁酸-胆汁淤积症的三角关系及潜在的益生菌策略。
Gut Microbes. 2023 Jan-Dec;15(1):2181930. doi: 10.1080/19490976.2023.2181930.
7
Knockout of secretin ameliorates biliary and liver phenotypes during alcohol-induced hepatotoxicity.敲除促胰液素可改善酒精性肝毒性期间的胆汁和肝脏表型。
Cell Biosci. 2023 Jan 9;13(1):5. doi: 10.1186/s13578-022-00945-w.
8
Predictive value of serum bile acids as metabolite biomarkers for liver cirrhosis: a systematic review and meta-analysis.血清胆汁酸作为肝硬化代谢生物标志物的预测价值:系统评价和荟萃分析。
Metabolomics. 2022 Jun 27;18(7):43. doi: 10.1007/s11306-022-01890-y.
9
Gut microbiome in liver pathophysiology and cholestatic liver disease.肠道微生物群在肝脏病理生理学和胆汁淤积性肝病中的作用
Liver Res. 2021 Sep;5(3):151-163. doi: 10.1016/j.livres.2021.08.001. Epub 2021 Aug 8.
10
Network pharmacology analysis and molecular docking to unveil the potential mechanisms of San-Huang-Chai-Zhu formula treating cholestasis.网络药理学分析和分子对接揭示三黄柴术方治疗胆汁淤积的潜在机制。
PLoS One. 2022 Feb 23;17(2):e0264398. doi: 10.1371/journal.pone.0264398. eCollection 2022.